Medtech Archives - Page 31 of 98 - Life Sciences Times

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

June 7, 2025

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

June 6, 2025

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

June 5, 2025

THIS WEEK'S STORIES

Allay Therapeutics Secures $57.5M in Series D Funding to Advance Post-Surgical Pain Therapy ATX101

June 5, 2025

Cyberattacks Disrupt Patient Care in Nearly 1 in 5 Healthcare Organizations, Omega Systems Report Finds

June 4, 2025

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

June 6, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Medtech

AI-Powered Tool Set to Revolutionize Type 1 Diabetes Diagnosis and Treatment

ZEISS CLARUS 700 Retinal Imaging System Receives Approval in China

HistoSonics Completes Enrollment in Pivotal Trial Testing Non-Invasive Kidney Tumor Treatment

Study Highlights Major Advantages of PharmaJet’s Needle-Free Tropis® ID System in Nigeria’s Polio Vaccination Efforts

Foldax Receives Indian Approval for First-Ever Commercial Polymer Mitral Heart Valve

Most Read

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

AI-Powered Tool Set to Revolutionize Type 1 Diabetes Diagnosis and Treatment

ZEISS CLARUS 700 Retinal Imaging System Receives Approval in China

Vera Whole Health and Anthem Expand Primary Care Access in Richmond Amid Physician Shortage

EDITOR PICKS

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

THIS WEEK'S STORIES

Allay Therapeutics Secures $57.5M in Series D Funding to Advance Post-Surgical Pain Therapy ATX101

Cyberattacks Disrupt Patient Care in Nearly 1 in 5 Healthcare Organizations, Omega Systems Report Finds

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

POPULAR CATEGORY

ABOUT US

FOLLOW US